Vigil Neuroscience (VIGL) News Today $7.86 -0.01 (-0.13%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$7.86 0.00 (-0.06%) As of 06/13/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VIGL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Two Sigma Investments LP Acquires 41,836 Shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL)Two Sigma Investments LP boosted its holdings in Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) by 44.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 136,920 shares of the company's stock after acquiring an additionJune 12 at 3:27 AM | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of ShareholdersJune 9, 2025 | prnewswire.comSquarepoint Ops LLC Acquires New Shares in Vigil Neuroscience, Inc. (NASDAQ:VIGL)Squarepoint Ops LLC acquired a new position in Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 113,596 shares of the company's stock, valued at approximately $193,000. SquarepJune 9, 2025 | marketbeat.comMillennium Management LLC Boosts Holdings in Vigil Neuroscience, Inc. (NASDAQ:VIGL)Millennium Management LLC grew its position in shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) by 23.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 343,814 shares of the company's stock after buyingJune 9, 2025 | marketbeat.comJane Street Group LLC Invests $83,000 in Vigil Neuroscience, Inc. (NASDAQ:VIGL)Jane Street Group LLC acquired a new position in Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 48,812 shares of the company's stock, valued at appJune 9, 2025 | marketbeat.comVigil Neuroscience, Inc. (NASDAQ:VIGL) Holdings Lifted by Two Sigma Advisers LPTwo Sigma Advisers LP lifted its stake in shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) by 243.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,100 shares of the company's stock after acquirinJune 8, 2025 | marketbeat.comVigil Neuroscience halts Phase 2 trial for ALSP treatmentJune 5, 2025 | investing.comVIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors ...June 5, 2025 | morningstar.comVIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the FirmJune 4, 2025 | prnewswire.comVigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSPJune 4, 2025 | globenewswire.comHC Wainwright Has Bearish Forecast for VIGL FY2026 EarningsVigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) - Stock analysts at HC Wainwright dropped their FY2026 earnings estimates for Vigil Neuroscience in a research note issued on Tuesday, May 27th. HC Wainwright analyst A. Fein now expects that the company will post earnings per share of ($0.84)May 30, 2025 | marketbeat.comStifel cuts Vigil Neuroscience stock rating, lowers target to $8May 29, 2025 | investing.comVigil Neuroscience (NASDAQ:VIGL) Downgraded by Stifel Nicolaus to HoldStifel Nicolaus downgraded shares of Vigil Neuroscience from a "buy" rating to a "hold" rating and set a $8.00 target price on the stock. in a research report on Wednesday.May 29, 2025 | marketbeat.comStifel Downgrades Vigil Neuroscience (VIGL)May 29, 2025 | msn.comHC Wainwright Reiterates "Neutral" Rating for Vigil Neuroscience (NASDAQ:VIGL)HC Wainwright reiterated a "neutral" rating and issued a $8.00 target price (down previously from $14.00) on shares of Vigil Neuroscience in a research report on Tuesday.May 28, 2025 | marketbeat.comHC Wainwright & Co. Downgrades Vigil Neuroscience (VIGL)May 28, 2025 | msn.comWoodline Partners LP Has $831,000 Position in Vigil Neuroscience, Inc. (NASDAQ:VIGL)Woodline Partners LP boosted its holdings in shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) by 239.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 488,756 shares of the coMay 28, 2025 | marketbeat.comWedbush Equities Analysts Reduce Earnings Estimates for VIGLVigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) - Investment analysts at Wedbush cut their FY2027 EPS estimates for Vigil Neuroscience in a research report issued on Thursday, May 22nd. Wedbush analyst L. Chico now forecasts that the company will post earnings of ($2.13) per share for the yeMay 27, 2025 | marketbeat.comWilliam Blair Issues Optimistic Outlook for VIGL EarningsVigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) - Equities researchers at William Blair lifted their Q2 2025 EPS estimates for Vigil Neuroscience in a research report issued to clients and investors on Thursday, May 22nd. William Blair analyst M. Minter now expects that the company will earnMay 27, 2025 | marketbeat.comVigil Neuroscience (NASDAQ:VIGL) Stock Rating Lowered by MizuhoMizuho downgraded shares of Vigil Neuroscience from a "strong-buy" rating to a "hold" rating in a research report on Friday.May 26, 2025 | marketbeat.comVigil Neuroscience (NASDAQ:VIGL) Stock Rating Lowered by GuggenheimGuggenheim downgraded Vigil Neuroscience from a "strong-buy" rating to a "hold" rating in a report on Thursday.May 26, 2025 | marketbeat.comPoint72 Asset Management L.P. Cuts Stock Holdings in Vigil Neuroscience, Inc. (NASDAQ:VIGL)Point72 Asset Management L.P. decreased its holdings in shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) by 84.4% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 250,000 shares of the company's stock after selling 1,350,000 shares during theMay 26, 2025 | marketbeat.comEquities Analysts Issue Forecasts for VIGL FY2027 EarningsVigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) - Investment analysts at William Blair issued their FY2027 EPS estimates for Vigil Neuroscience in a research note issued on Thursday, May 22nd. William Blair analyst M. Minter expects that the company will post earnings of ($1.78) per share foMay 25, 2025 | marketbeat.comVigil Neuroscience (NASDAQ:VIGL) Rating Lowered to Hold at Citizens JmpCitizens Jmp cut shares of Vigil Neuroscience from a "strong-buy" rating to a "hold" rating in a report on Thursday.May 25, 2025 | marketbeat.comVigil Neuroscience, Inc. (NASDAQ:VIGL) Receives Consensus Recommendation of "Hold" from AnalystsShares of Vigil Neuroscience, Inc. (NASDAQ:VIGL - Get Free Report) have been given an average rating of "Hold" by the five analysts that are covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and two have given a buy recoMay 25, 2025 | marketbeat.comVigil Neuroscience Analyst Ratings and Price Targets | NASDAQ:VIGL | BenzingaMay 24, 2025 | benzinga.comVIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil ...May 24, 2025 | morningstar.comJMP Securities Reaffirms Market Perform Rating for Vigil Neuroscience (NASDAQ:VIGL)JMP Securities reiterated a "market perform" rating on shares of Vigil Neuroscience in a research report on Thursday.May 24, 2025 | marketbeat.com$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)May 24, 2025 | financialpost.com$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)May 24, 2025 | financialpost.comVigil Neuroscience (NASDAQ:VIGL) Receives Market Perform Rating from William BlairWilliam Blair restated a "market perform" rating on shares of Vigil Neuroscience in a research report on Thursday.May 24, 2025 | marketbeat.comVigil Neuroscience (NASDAQ:VIGL) Earns Neutral Rating from WedbushWedbush restated a "neutral" rating and issued a $8.00 price target (down from $13.00) on shares of Vigil Neuroscience in a research report on Thursday.May 24, 2025 | marketbeat.com$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)May 24, 2025 | globenewswire.comSanofi to spend $470M for Watertown biotech’s Alzheimer’s drugMay 23, 2025 | bizjournals.comVigil Neuroscience to be acquired by Sanofi for $8.00 per shareMay 23, 2025 | finance.yahoo.comShareholder Alert: The Ademi Firm Investigates Whether Vigil Neuroscience Inc. Is Obtaining a Fair Price for Its Public ShareholdersMay 22, 2025 | tmcnet.comSanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience AcquisitionMay 22, 2025 | uk.finance.yahoo.comVigil Neuroscience Stock Triples Pre-market On Acquisition By Sanofi: Retail Goes Super BullishMay 22, 2025 | msn.comVIGL Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Vigil Neuroscience, Inc. is Fair to ShareholdersMay 21, 2025 | tmcnet.comSanofi to acquire Vigil Neuroscience in Alzheimer’s drug playMay 21, 2025 | finance.yahoo.comSanofi to Buy Vigil Neuroscience for About $470 MillionMay 21, 2025 | wsj.comVigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by SanofiMay 21, 2025 | globenewswire.comSanofi to acquire Vigil Neuroscience in $470 million dealMay 21, 2025 | reuters.comTrustees of Columbia University in the City of New York Buys New Shares in Vigil Neuroscience, Inc. (NASDAQ:VIGL)Trustees of Columbia University in the City of New York purchased a new stake in shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 192,973 shares ofMay 20, 2025 | marketbeat.comSphera Funds Management LTD. Sells 145,175 Shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL)Sphera Funds Management LTD. reduced its position in Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) by 8.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,502,429 shares of the company's stock afteMay 18, 2025 | marketbeat.comHC Wainwright Expects Higher Earnings for Vigil NeuroscienceVigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) - HC Wainwright raised their Q2 2025 earnings per share (EPS) estimates for shares of Vigil Neuroscience in a research note issued on Thursday, May 8th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings of ($0.48May 13, 2025 | marketbeat.comQ2 EPS Estimate for Vigil Neuroscience Increased by AnalystVigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) - Investment analysts at Wedbush increased their Q2 2025 earnings per share estimates for Vigil Neuroscience in a report issued on Wednesday, May 7th. Wedbush analyst L. Chico now forecasts that the company will earn ($0.39) per share for the qMay 13, 2025 | marketbeat.comVigil Neuroscience, Inc.: Vigil Neuroscience Reports First Quarter 2025 Financial Results and Provides Recent Business UpdatesMay 7, 2025 | finanznachrichten.deWedbush Reaffirms Outperform Rating for Vigil Neuroscience (NASDAQ:VIGL)Wedbush restated an "outperform" rating and issued a $13.00 price target on shares of Vigil Neuroscience in a report on Monday.May 7, 2025 | marketbeat.comVigil Neuroscience Reports First Quarter 2025 Financial Results and Provides Recent Business UpdatesMay 7, 2025 | globenewswire.com Get Vigil Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address VIGL Media Mentions By Week VIGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VIGL News Sentiment▼1.440.88▲Average Medical News Sentiment VIGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VIGL Articles This Week▼73▲VIGL Articles Average Week Get Vigil Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EVO News Today SPRY News Today OCUL News Today VERA News Today ANIP News Today TVTX News Today BGM News Today AMPH News Today CALT News Today GPCR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VIGL) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vigil Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vigil Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
